Our current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE@Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ+ Allies), Veterans Leadership Network (VLN) and Women’s Initiative for Leading at Lilly (WILL). This role owns business development forecasting for white-space opportunities—therapeutic areas and modalities outside Lilly's established business units, such as rare disease, women's health, respiratory, ophthalmology, infectious disease, and platform, technology, or novel-modality deals where the eventual indication set is still open.